Johnson & Johnson

crown royalty king queen win
Biotech

J&J's IL-23 drug defeats Sotyktu in phase 3 psoriasis trial

After being touted as a rival to BMS’ reigning psoriasis med Sotyktu for months, J&J’s IL-23 drug looks like it has a shot at taking the crown.
James Waldron Sep 17, 2025 9:45am
Alps parachute rainbow mountains

Takeda taps longtime Lilly exec as US head—Chutes & Ladders

Sep 12, 2025 8:30am
Ronovos robotic Carina system

Surgical robot maker Ronovo raises $67M with J&J backing

Sep 9, 2025 2:00pm
heart model with cardiologist

J&J delivers 10-year Impella gains in severe heart attacks

Sep 2, 2025 1:30pm
Close-up of Benjamin Franklins eyes peering through hundred dollar bills

The highest-paid medtech CEOs of 2024

Jul 28, 2025 6:00am
Johnson Johnson

J&J boosts outlook amid growing cardiac device sales

Jul 16, 2025 11:47am